Á lódáil...
Introducing Vernakalant into Clinical Practice
Vernakalant is an antiarrhythmic drug licensed for the pharmacological cardioversion of recent onset AF. Randomised clinical trials, backed up by real-world experience, have confirmed its efficacy at restoring sinus rhythm. Vernakalant can be administered simply with a short time to action, facilita...
Na minha lista:
| Foilsithe in: | Arrhythm Electrophysiol Rev |
|---|---|
| Main Authors: | , |
| Formáid: | Artigo |
| Teanga: | Inglês |
| Foilsithe: |
Radcliffe Cardiology
2019
|
| Ábhair: | |
| Rochtain Ar Líne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6434499/ https://ncbi.nlm.nih.gov/pubmed/30918671 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15420/aer.2018.71.2 |
| Clibeanna: |
Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!
|